Lv41
790 积分 2025-04-27 加入
Neoadjuvant Selective RET Inhibitor for Medullary Thyroid Cancer: A Case Series
3小时前
待确认
Management of Differentiated Thyroid Cancer
14天前
已完结
Prognostic Value of Hematological Inflammatory Indices (PLR, NLR, SII) in Medium and High‐Risk Papillary Thyroid Carcinoma: A Multicenter Cohort Study
14天前
已完结
Compartmental Surgery for Early to Advanced Tongue Cancers
2个月前
已完结
CALCITONIN SECRETORY INDEX AND UNSUSPECTED NODAL DISEASE IN MEDULLARY THYROID CARCINOMA
2个月前
已完结
Some Possible Confounders in Study of Patient Age and Progression of Low-risk Papillary Thyroid Carcinoma
3个月前
已完结
The Usefulness of the International Grading System in the Management of Sporadic Medullary Thyroid Carcinoma
3个月前
已完结
Use of Neoadjuvant Vandetanib in Aggressive Pediatric Medullary Thyroid Carcinoma
3个月前
已关闭
Postoperative Radiotherapy for Medullary Thyroid Cancer: A Meta‐Analysis of Survival and Recurrence Outcomes
4个月前
已完结
Insights into highly selective RET inhibitors in medullary thyroid cancer
4个月前
已完结
皖公网安备34019202002308
